However, as far as we know this is the first report studying coagulation factors XI, XII, and XIII in COVID-19, as most of the published studies have focused in other parameters such as platelets, D-dimer, fibrin, fibrinogen, aPTT, PT, and even factor VIII and thrombin (18, 22, 23). The gene discussed is F2; the disease is COVID-19.